Literature DB >> 28487136

Role of MicroRNAs in Type 2 Diabetes and Associated Vascular Complications.

Joyita Banerjee1, Vijay Nema2, Yogita Dhas1, Neetu Mishra3.   

Abstract

Type 2 diabetes mellitus (T2DM) has become a major health threat worldwide. MicroRNAs (miRNAs) are a group of non-coding RNAs known to regulate various biological processes including the pathogenesis of T2DM. Recent studies have pointed out that specific miRNAs play a critical role in controlling β cell activities and the development of diabetic vascular complications. Their association with the disease pathogenesis and omnipresence in body fluids have made them important players for prognosis, diagnosis and management of T2DM. Owing to the limitations of classical biomarkers of diabetes such as fasting plasma glucose, glycosylated haemoglobin (HbA1c) lack in predicting the risk of development of diabetes complications in a susceptible population. The miRNAs can act as ideal biomarkers for diabetes associated complications. Identification of specific miRNA signatures to detect diabetes and ideally to find out the risk of development of diabetes-associated complications in susceptible population is the essential requirement of the present clinical strategies for controlling diabetes worldwide. In this article, we summarize the potential miRNAs and miRNA signatures involved in the β cell activities and diabetes associated macrovascular and microvascular complications.
Copyright © 2017 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Macrovascular complications; Microvascular complications; Type 2 diabetes mellitus; microRNAs; β cell activities

Mesh:

Substances:

Year:  2017        PMID: 28487136     DOI: 10.1016/j.biochi.2017.05.007

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  20 in total

1.  Senescence-associated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes.

Authors:  Joyita Banerjee; Swagata Roy; Yogita Dhas; Neetu Mishra
Journal:  Clin Exp Med       Date:  2019-11-15       Impact factor: 3.984

Review 2.  MicroRNA and Diabetic Bone Disease.

Authors:  Souad Daamouch; Lejla Emini; Martina Rauner; Lorenz C Hofbauer
Journal:  Curr Osteoporos Rep       Date:  2022-06-08       Impact factor: 5.163

Review 3.  The Destiny of Glucose from a MicroRNA Perspective.

Authors:  Paola Mirra; Cecilia Nigro; Immacolata Prevenzano; Alessia Leone; Gregory Alexander Raciti; Pietro Formisano; Francesco Beguinot; Claudia Miele
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-26       Impact factor: 5.555

Review 4.  Molecular biomarkers in diabetes mellitus (DM).

Authors:  Seyed Mohsen Aghaei Zarch; Masoud Dehghan Tezerjani; Mehrdad Talebi; Mohammad Yahya Vahidi Mehrjardi
Journal:  Med J Islam Repub Iran       Date:  2020-04-01

Review 5.  Recent Updates on Vascular Complications in Patients with Type 2 Diabetes Mellitus.

Authors:  Chan-Hee Jung; Ji-Oh Mok
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

Review 6.  Programming of Vascular Dysfunction in the Intrauterine Milieu of Diabetic Pregnancies.

Authors:  Nada A Sallam; Victoria A C Palmgren; Radha D Singh; Cini M John; Jennifer A Thompson
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

Review 7.  Regulating microRNA expression: at the heart of diabetes mellitus and the mitochondrion.

Authors:  Quincy A Hathaway; Mark V Pinti; Andrya J Durr; Shanawar Waris; Danielle L Shepherd; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-06       Impact factor: 4.733

8.  Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.

Authors:  Qiaowei Fan; Bingrong Liu
Journal:  Onco Targets Ther       Date:  2018-05-01       Impact factor: 4.147

Review 9.  MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications.

Authors:  Suniti Vaishya; Rucha D Sarwade; Vasudevan Seshadri
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-23       Impact factor: 5.555

Review 10.  Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.

Authors:  John R Petrie; Tomasz J Guzik; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2017-12-11       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.